This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. Research Beam Model: Research Beam Product ID: 15343 5400 USD New
European Respiratory Disease Testing Market 2014: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
 
 

European Respiratory Disease Testing Market 2014: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

  • Category : Diagnostic and Biotech
  • Published On : January   2014
  • Pages : 0
  • Publisher : VPGMarketResearch.com
 
 
 

Complete report $8,300.  DataPack (test volumes, sales forecasts, supplier shares) $5,400.



This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.



About this Report



This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK).  Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales forecasts by country and market segment, including:



     - Hospitals

     - Commercial/Private Labs

     - Physician Offices

     - Public Health Labs      



In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.  Also, the report:



     -  Examines market applications of Molecular Diagnostics,  

        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen



     -  Reviews features and operating characteristics of major analyzers used

        for respiratory disease testing;



     -  Profiles key suppliers and potential market entrants developing innovative

        technologies and products; and



     -  Analyzes emerging opportunities, alternative market penetration strategies,  

         market entry barriers/risks, and strategic planning issues.



Methodology



The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries.



In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.



Contains 335 pages and 76 tables



 


../toc/TOCTOT%20AnalysisoftheRespiratoryDiseaseTestingMarketinEurope%20AdenovirusInfluenzaLegionellaMononucleosisMycoPNERSVTB.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT